NCT01096875 Effects of Atorvastatin on Endothelial Progenitor Cells After Coronary Surgery Status COMPLETED Phase PHASE4
NCT01081548 A Clinical Trial Study to Evaluate Efficacy and Safety of Atorvastatin in Korean Patients With Hypercholesterolemia Status COMPLETED Phase PHASE4
NCT01072097 The Effect of Atorvastatin on Androgens, Glucose Metabolism and Inflammation in Polycystic Ovary Syndrome (PCOS) Women Status COMPLETED Phase NA
NCT01059864 Study Of The Effects Of Atorvastatin On Cholesterol Levels In Rheumatoid Arthritis Patients Taking CP-690,550 Status COMPLETED Phase PHASE2
NCT01058057 Atorvastatin Pre-Treatment Influences the Risk of Percutaneous Coronary Intervention (PCI) Study 2 Status UNKNOWN Phase PHASE3
NCT01041729 Long-term Pleiotropic Effect of Statins in Patients With Peripheral Arterial Disease Status COMPLETED Phase PHASE4
NCT01040936 Intensive Lipid Lowering Treatment in Non-ST-elevation Acute Coronary Syndrome (NSTE-ACS) Patients Status UNKNOWN Phase PHASE4
NCT01033058 Intensive Statin Treatment for STEMI Patients Undergoing Primary PCI Status UNKNOWN Phase PHASE4
NCT01023607 Evaluation of Statin-induced Lipid-rich Plaque Progression by Optical Coherence Tomography (OCT) Combined With Intravascular Ultrasound (IVUS) Status COMPLETED Phase PHASE4
NCT01013870 Mission Connect Mild Traumatic Brain Injury (TBI) Integrated Clinical Protocol Status TERMINATED Phase PHASE2
NCT00993915 Study On Liprimar (Atorvastatin) In Patients With Coronary Heart Disease (CHD) And High Risk Of Cardiovascular Complications Status COMPLETED Phase N/A
NCT00991705 A Study to Evaluate the Effect of Atorvastatin on the Pharmacokinetics of Fimasartan in Healthy Male Volunteers Status COMPLETED Phase PHASE1
NCT00979940 Effects of Short Term, High Dose Atorvastatin Therapy on Periprocedural Myonecrosis and Platelet Inhibition After Percutaneous Coronary Intervention (PCI) Status TERMINATED Phase NA
NCT00973986 Effect of CYP3A Genetic Polymorphisms on the Pharmacokinetics of Atorvastatin Status COMPLETED Phase PHASE1
NCT00973271 Diazoxide Choline Controlled-Release Tablet (DCCR) for Very High Triglycerides Status WITHDRAWN Phase PHASE3